B. Riley Securities Maintains Buy on Strive, Raises Price Target to $26
B. Riley Securities analyst Fedor Shabalin maintains Strive (NASDAQ:ASST) with a Buy and raises the price target from $16 to $26.
Stocks · News reference
U.S. stocks rose Thursday; Summit Therapeutics jumped 10.1% after Phase III results, while Snowflake and other stocks rallied.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
B. Riley Securities analyst Fedor Shabalin maintains Strive (NASDAQ:ASST) with a Buy and raises the price target from $16 to $26.
BitMine stock traded higher Thursday as Ether rose 3.51% and analysts highlighted treasury expansion strategies.
Stocks rallied and Treasury yields retreated from three-year highs after Fed Governor Waller signaled he could back a rate hold, sending bitcoin above $80,000.
Webull stock surges Thursday amid a sector-wide retail brokerage rally, competitor upgrades, and robust Q2 earnings momentum.